NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 00338-1134-03 — Amino acid 4.25% solution with 10% dextrose IVAI (176 hospitals, 26,485–26,674 samples)
• NDC 00904-6290-61 — Atorvastatin 10 mg tabletsAI (724 hospitals, 25,918–26,674 samples)
• NDC 16714-0643-01 — Moxifloxacin eye dropsAI (227 hospitals, 25,737–26,673 samples)
• NDC 65862-0782-01 — Methenamine hippurate 1 gram tabletsAI (472 hospitals, 26,140–26,671 samples)
• NDC 00904-6401-61 — Tamsulosin 0.4 mg capsulesAI (302 hospitals, 26,164–26,668 samples)
• NDC 00009-0698-01 — Methylprednisolone sodium succinate injection, 1000 mgAI (847 hospitals, 19,828–26,659 samples)
• NDC 70095-0024-01 — Pantoprazole sodium 40 mg IV injectionAI (309 hospitals, 25,712–26,657 samples)
• NDC 21922-0045-47 — Mesalamine 4 g/60 mL rectal enemaAI (121 hospitals, 25,735–26,653 samples)
• NDC 00168-0202-30 — clindamycin 1 % topical gelAI (270 hospitals, 25,751–26,651 samples)
• NDC 00378-9055-16 — LIDOCAINE 5 % TOPICAL PATCHAI (113 hospitals, 25,751–26,651 samples)
• NDC 00378-6470-44 — Scopolamine 1.5 mg patch (1 mg over 72 hours)AI (162 hospitals, 25,700–26,645 samples)
• NDC 45802-0257-42 — MOMETASONE 0.1 % TOPICAL CREAMAI (84 hospitals, 25,734–26,643 samples)
• NDC 17478-0253-10 — Fluorescein 10% injection, 5 mL vialAI (521 hospitals, 25,976–26,642 samples)
• NDC 51672-4116-06 — Metronidazole 0.75% topical gelAI (504 hospitals, 25,731–26,640 samples)
• NDC 00574-2042-30 — Lidocaine-prilocaine numbing creamAI (223 hospitals, 25,776–26,640 samples)
• NDC 51293-0811-01 — Phenazopyridine 200 mg tabletAI (174 hospitals, 26,217–26,640 samples)
• NDC 61314-0647-05 — Tobramycin and dexamethasone eye drops suspensionAI (354 hospitals, 25,683–26,637 samples)
• NDC 65162-0351-09 — Sildenafil 20 mg tablet for pulmonary hypertensionAI (538 hospitals, 25,935–26,637 samples)
• NDC 43825-0606-41 — Recombinant thrombin topical solution kitAI (317 hospitals, 26,289–26,631 samples)
• NDC 70954-0600-10 — Fluoxetine oral liquid, 20 mg per 5 mLAI (308 hospitals, 25,730–26,630 samples)
• NDC 61314-0656-10 — CIPROFLOXACIN 0.3 % EYE DROPSAI (132 hospitals, 25,712–26,621 samples)
• NDC 00517-7305-01 — Sodium phosphate oral solutionAI (150 hospitals, 26,212–26,617 samples)
• NDC 00517-7305-25 — Sodium phosphate oral solutionAI (125 hospitals, 26,212–26,617 samples)
• NDC 62756-0129-44 — Pantoprazole 40 mg IV injectionAI (239 hospitals, 25,676–26,612 samples)
• NDC 61570-0131-25 — Silvadene 1% silver sulfadiazine skin creamAI (371 hospitals, 25,573–26,608 samples)
• NDC 24208-0295-05 — Tobramycin and dexamethasone eye dropsAI (319 hospitals, 25,634–26,597 samples)
• NDC 51672-1298-02 — Ketoconazole 2% creamAI (280 hospitals, 25,714–26,596 samples)
• NDC 55150-0256-50 — Lidocaine 2% injection, 50 mL vialAI (113 hospitals, 26,162–26,594 samples)
• NDC 63323-0824-25 — Dextrose 10% in water IV solutionAI (93 hospitals, 26,180–26,594 samples)
• NDC 62559-0138-11 — Hydrocortisone enemaAI (201 hospitals, 25,726–26,590 samples)
• NDC 00409-3308-11 — Acetylcysteine 20% oral solutionAI (233 hospitals, 25,726–26,590 samples)
• NDC 69238-2512-09 — Nitrofurantoin oral liquid, 25 mg per 5 mLAI (96 hospitals, 25,726–26,590 samples)
• NDC 61314-0396-03 — Cyclopentolate 1% eye dropsAI (448 hospitals, 25,675–26,584 samples)
• NDC 00006-5424-02 — Black widow spider antivenin injection kitAI (273 hospitals, 25,675–26,584 samples)
• NDC 00904-6503-61 — Celecoxib 200 mg capsulesAI (329 hospitals, 26,155–26,578 samples)
• NDC 58914-0301-80 — Nitroglycerin 0.4% ointment, 30 g tubeAI (214 hospitals, 25,603–26,575 samples)
• NDC 00409-4887-24 — Sterile water for injectionAI (345 hospitals, 26,386–26,566 samples)
• NDC 00409-4887-25 — Sterile water for injectionAI (301 hospitals, 26,386–26,566 samples)
• NDC 63323-0185-09 — Sterile water for injectionAI (114 hospitals, 26,386–26,566 samples)
• NDC 62559-0159-01 — fluvoxaMINE 50 mg tabletAI (691 hospitals, 25,946–26,558 samples)
• NDC 66794-0235-41 — Dexmedetomidine IV infusion in salineAI (131 hospitals, 25,730–26,549 samples)
• NDC 23155-0345-32 — Propofol intravenous emulsion, 1000 mg per 100 mLAI (115 hospitals, 25,960–26,545 samples)
• NDC 00009-0315-08 — Absorbable gelatin spongeAI (301 hospitals, 25,747–26,539 samples)
• NDC 70710-1643-05 — Verapamil 1 mg in saline injectionAI (166 hospitals, 25,883–26,531 samples)
• NDC 69784-0240-10 — Carboprost injection 250 mcg per mLAI (109 hospitals, 25,423–26,530 samples)
• NDC 00121-4675-05 — Valproate sodium oral liquid, 250 mg per 5 mLAI (680 hospitals, 26,032–26,527 samples)
• NDC 00168-0055-46 — Betamethasone dipropionate 0.05% external creamAI (152 hospitals, 25,647–26,520 samples)
• NDC 00591-3509-54 — Clonidine 0.2 mg/24-hour transdermal patchAI (303 hospitals, 25,609–26,518 samples)
• NDC 67850-0150-00 — Pantoprazole 40 mg IV injectionAI (289 hospitals, 25,464–26,508 samples)
• NDC 00409-4264-11 — Hydromorphone 0.5 mg injection syringeAI (453 hospitals, 17,552–26,507 samples)